drugset / Trial / NCT07342296
Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38
RandomizedCrossoverQuadruple-blindBasic science
Summary
Pituitary Adenylate Cyclase Activating Polypeptide-38 (PACAP-38) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether PACAP-38 administration can trigger aura in individuals with a diagnosis of migraine with aura.
Timeline
- Start
- 2026-02-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PACAP38 | Peptide | — | Intravenous |